Ellington Management Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Ellington Management Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,700	Closed	-$188K	–	777
2015 Q4	$188K	Buy	+12,700	New	+$213K	0.07%	479
2015 Q2	–	Sell	-28,498	Closed	-$433K	–	965
2015 Q1	$433K	Buy	+28,498	New	+$370K	0.09%	343

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ellington Management Group's MNTA Position: Q1 2016 in Review

Ellington Management Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2016, closing a stake of 12,700 shares — an estimated $188K sold.

Ellington Management Group first reported a position in MNTA in Q1 2015 and held it in 2 quarters. The position peaked at $433K in Q1 2015. 148 funds tracked by Wall St. Rank hold MNTA as of Q1 2016.

Ellington Management Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Ellington Management Group sold 12,700 Momenta Pharmaceuticals, Inc. shares in Q1 2016, an estimated $188K.
Ellington Management Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
Ellington Management Group's Momenta Pharmaceuticals, Inc. position peaked at $433K in Q1 2015.
148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2016.

Based on Ellington Management Group's 13F filing for Q1 2016, filed 16 May 2016.